Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0010346 (
Crohn's disease
)
21,615
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The serum levels of lysozyme, serum electrophoresis, and serum immunoglobulins were determined prospectively in 101 patients with ulcerative colitis, ulcerative proctitis,
Crohn's disease
, or nonclassifiable nonspecific
inflammatory bowel disease
. Although the mean serum lysozyme concentration of patients with
Crohn's disease
(10.5 +/- 6.8 microgram/ml) and ulcerative colitis (9.6 +/- 4.1 microgram/ml) performed by a standardized lysoplate method was significantly greater than normal controls (6.0 +/- 1.5 microgram/ml), the results did not correlate with the diagnosis nor with the degree of disease activity. Individually separated protein fractions and serum immunoglobulins also did not correlate with the serum lysozyme levels. This study indicates that measurement of the level of serum lysozyme in individual patients is not helpful in determining the cause or degree of activity of nonspecific
inflammatory bowel disease
.
...
PMID:Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease. 66 22
Inflammatory bowel disease
(
IBD
) patients in the United States of America (USA) and Czechoslovakia (CSSR) were categorized by clinical, pathological, and radiological criteria as having
Crohn's disease
(CD) or ulcerative colitis (UC) and were tested with five skin test antigens [Candida, mumps, purified protein derivative (PPD), streptokinase-streptodornase (SK-SD), and trichophytin] at two different dilutions in an attempt to elicit some evidence of anergy. No significant differences were encountered between the USA and CSSR populations or between any patient group and its controls.
...
PMID:Skin test reactivity in inflammatory bowel disease in the United States and Czechoslovakia. 66 29
Rectal biopsies were examined from 22 patients with Salmonella infection of food-poisoning type and from seven patients with
inflammatory bowel disease
and coincidental Salmonella infection. In the former group the changes observed were mucosal oedema with acute inflammation of varying severity but with preservation of the crypt architecture. Crypt abscesses were present in a few cases but were usually localized in the crypt and mucus depletion only occurred with severe inflammation. These features are not specific and are similar to those seen in other types of infective colitis such as Shigella dysentery, gonococcal proctitis and amoebic colitis. In the majority of cases of infective colitis the appearances are usually sufficiently distinctive, however, to distinguish them from those seen in ulcerative colitis and
Crohn's disease
. The changes in the biopsies from the seven patients with coincidental Salmonella infection were in general those of the underlying idiopathic
inflammatory bowel disease
.
...
PMID:The rectal biopsy appearances in Salmonella colitis. 66 91
It is stated that 10-20% of cases of non-specific
inflammatory bowel disease
cannot be classified. Thirty such cases, designated colitis indeterminate at the time of colectomy, were identified from the pathology files of St. Mark's Hospital. The Histopathological features of the surgical specimens and any available biopsy specimens were studied. In nearly all the cases urgent surgery had been required and the features of incipient or established fulminating disease were present. The pathology of these cases of
Crohn's disease
and ulcerative colitis overlapped, and differentiating features were scant or unreliable. Accepted criteria of
Crohn's disease
--namely, fissuring ulceration, transmural inflammation, and a maintained goblet-cell population--were found in cases subsequently proved to be ulcerative colitis. Disease activity greatly affected the evaluation of morphological features. Many of the difficulties were resolved when biopsy material obtained during a quiescent phase was examined. The specimens gave a dynamic perspective of the disease process, often more valuable than the static, non-specific picture of acute disease seen in the surgical specimens. Case of colitis indeterminate form a small distinctive group in the spectrum of
inflammatory bowel disease
which is characterised by a common pattern of pathology that presents a diagnostic dilemma.
...
PMID:Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'. 67 Apr 13
Several animal transmission studies have indicated that
Crohn's disease
may be caused by a filterable agent. Filtrates of homogenized tissues were prepared from 8 patients with
Crohn's disease
, 9 patients with chronic ulcerative colitis, and 20 control patients without
inflammatory bowel disease
. Conventional bacteriological cultures and hypertonic cultures for cell wall-defective bacterial variants were performed on the filtrates. Bacterial revertants (parent forms) of cell wall-defective variants were obtained from filtrates of various tissues including mesenteric lymph nodes of all patients with
Crohn's disease
. In no instance were revertants cultured from tissue filtrates of the other patients. The 11 revertants isolated from the 8 patients were identified as Pseudomonas-like bacteria, most closely identifiable with group Va.
...
PMID:Cell wall-defective variants of pseudomonas-like (group Va) bacteria in Crohn's disease. 68 Apr 90
Serum lysozyme activity was determined in the sera of 70 patients with
inflammatory bowel disease
by the lysoplate method. Serum lysozyme levels were significantly elevated only in patients with
Crohn's disease
of the small bowel. Patients with either granulomatous or ulcerative colitis had serum lysozyme values not different from normals, irrespective of activity of their disease.
...
PMID:Serum lysozyme activity in inflammatory bowel disease. 68 4
During 1976, 50 patients were admitted to two general hospitals for the investigation or treatment of nonspecific
inflammatory bowel disease
. There were more patients admitted with
Crohn's disease
(23) than proctocolitis (11). Half of those patients admitted with
Crohn's disease
required surgical treatment, the majority for small bowel obstruction. Five patients were admitted for the treatment of an acute attack of proctocolitis; these patients were all previously undiagnosed, were all admitted urgently and all responded to medical treatment.
...
PMID:Nonspecific inflammatory bowel disease in two general hospitals. 70 80
Of 52 student patients with chronic
inflammatory bowel disease
who were observed at Stanford University over a three-year period, 16 had
Crohn
disease, 17 had ulcerative colitis and 19 had ulcerative proctitis. Patients with ulcerative colitis had relatively few complications. During the study period, only two students from the entire group of 52 were obliged to interrupt college attendance because of bowel disease or complications. Of the patients, 33 were first observed on remission or attained remission during the three-year observation period. Incidence and prevalence rates for
Crohn
disease and ulcerative colitis were comparable with age-specific rates from other published studies. At Stanford, the high reported frequency of proctitis, which exceeded that of proximal ulcerative colitis, was possibly a reflection of the diagnostic zeal with which patients with rectal bleeding were evaluated at the student health service.
...
PMID:Inflammatory bowel disease among college students. 72 19
A survey of the incidence and prevalence of
Crohn's disease
in the Jewish population of Tel-Aviv-Yafo was carried out from 1970 to 1976. The annual incidence rate was 1.28, and the prevalence was 12.31 per 10(5) population. The prevalence of 16.69 per 10(5) population among Ashkenazi jews was significantly higher than that found in "non-Ashkenazi" Jews, 4.19 per 10(5) population. Even so,
Crohn's disease
is significantly less common in Tel-Aviv than outside Israel, according to most recently published surveys. Similarly, the complication, surgery, and mortality rate are less marked than those reported from other studies. These figures confirm the authors' impression that
inflammatory bowel disease
in general is less common and possible less severe in Tel-Aviv than in the United State and Western Europe. The strikingly higher prevalence in the Ashkenazi community, especially in the Israeli-born population, suggests a hereditary predisposition. The apparent differences among Askhenazi Jews in various parts of the world may relate to environmental factors.
...
PMID:Crohn's disease in the Jewish population of Tel-Aviv-Yafo. Epidemiologic and clinical aspects. 75 45
The etiology, pharmacotherapy and management of the two major types of
inflammatory bowel disease
--ulcerative colitis and
Crohn's disease
--are reviewed. Sulfasalazine and topical corticosteroids (i.e., hydrocortisone, hydrocortisone acetate or methylprednisolone acetate) are effective in many patients with mild distal ulcerative colitis. Maintenance sulfasalazine therapy significantly reduces the relapse rate in ulcerative colitis. Systemic corticosteroids (i.e., prednisone, prednisolone or methylprednisolone) have improved the survival rate of patients with moderate and severe ulcerative colitis. Antacids should be given regularly during high-dose steroid therapy to prevent gastritis. If oral steroids are ineffective, the use of parenteral corticosteroids (hydrocortisone sodium succinate or methylprednisolone sodium succinate) is suggested. Both sulfasalazine and corticosteroids appear to be effective in the treatment of
Crohn's disease
but require further investigation, however, if patients fail to respond to this therapy, oral corticosteriods, in low dosages, given concomitantly with azathioprine (currently under evaluation) is suggested.
...
PMID:Pharmacotherapy of inflammatory bowel disease. 78 36
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>